EMERGEX
Company Overview
Social Media Profiles
About Emergex
Description
Emergex specializes in the development of innovative vaccines utilizing T-cell technology to combat viral and bacterial infections. Focused on enhancing immune responses, the company aims to deliver effective solutions in the biotechnology and life sciences sector, addressing critical health challenges globally.
Specialties
T-cell vaccine development
Viral infection immunity
Bacterial infection solutions
Innovative immunotherapy
Global health challenges
Products & Services
T-cell vaccines
Immunotherapy candidates
Infectious disease treatments
Viral infection solutions
Bacterial infection solutions
Contact Information
No contact information available
Competitors & Similar Companies(10)
Moderna, Inc.
Massachusetts, • United States
BioNTech SE
Rheinland-Pfalz, • Germany
CureVac N.V.
GSK (GlaxoSmithKline)
Hillingdon, • United Kingdom
Sanofi
Île-De-France, • France
Novavax, Inc.
Maryland, • United States
Vaxart, Inc.
California, • United States
Inovio Pharmaceuticals, Inc.
Pennsylvania, • United States
Valneva SE
Auvergne-Rhône-Alpes, • France
Immunovant, Inc.
News & Media
Search Terms:
emergex vaccinesemergex
Search Topics:
AcquisitionAI: Product LaunchInvestment: Approval FundingProject: Bid and AuctionBusiness ExpansionFinancing and FundraisingInvestmentJoint VentureLeadership Change (CXO)MergerPartnershipProduct LaunchPublic Offering (IPO)RebrandingReorganizationRestructuringValuation
Frequently Asked Questions about Emergex
Where is Emergex located?
The headquarter of Emergex is located in Abingdon, England, United Kingdom
What is the official website of Emergex?
The official website of Emergex is https://www.emergexvaccines.com
What industry does Emergex belong to?
Emergex belongs to the Biotechnology, Biotechnology and Life Sciences industry.
What are the specialties of Emergex?
Emergex specializes in T-cell vaccine development, Viral infection immunity, Bacterial infection solutions, Innovative immunotherapy, Global health challenges.
What products and services is Emergex likely to offer?
Emergex offers T-cell vaccines, Immunotherapy candidates, Infectious disease treatments, Viral infection solutions, Bacterial infection solutions.
Who are the competitors of Emergex?
Competitors of Emergex are Moderna, Inc., BioNTech SE, CureVac N.V., GSK (GlaxoSmithKline), Sanofi, Novavax, Inc., Vaxart, Inc., Inovio Pharmaceuticals, Inc., Valneva SE, Immunovant, Inc..
What does Emergex do?
Emergex specializes in the development of innovative vaccines utilizing T-cell technology to combat viral and bacterial infections. Focused on enhancing immune responses, the company aims to deliver effective solutions in the biotechnology and life sciences sector, addressing critical health challenges globally.